Hair Loss Clinical Trials

A Clinical Trial seeking patients for a research study for the treatment of Hair Disease.

An enriched plasma hair re-growth study for the treatment of male and female pattern hair loss. Are you interested in participating in a Hair Loss study to evaluate the thinning of hair using Platelet Rich Plasma for male and females with Androgenetic Alopecia (AGA)? Participants will receive treatment at no ...

Alopecia Areata is an autoimmune disease that commonly results in unpredictable, patchy hair loss that can affect the scalp and body. Alopecia can have major impacts on the quality of life of those diagnosed. If you or a loved one suffer from hair loss caused by Alopecia, a research study ...

Seeking adults with severe to very severe alopecia areata. Alopecia areata is an autoimmune disease that commonly results in unpredictable, patchy hair loss that can affect the scalp and body. Alopecia can have major impacts on the quality of life of those diagnosed. If you or a loved one suffer ...

The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 when dosed for 6 weeks versus placebo in adult patients with moderate to severe Trichotillomania (TTM), also known as hair-pulling.  

The objective of this study is to evaluate the effectiveness of the study medication in those with moderate to severe alopecia areata. This is an up to 32-week study with up to 11 office visits.  

This will be a phase II prospective, open label, non-randomized study conducted to determine the safety and efficacy of Penguin TM cold cap system in preventing or reducing chemotherapy-induced alopecia in patients with early stage breast cancer undergoing chemotherapy. Eligible subjects will be enrolled to one of 4 study arms ...

This comparative study is a multi-center, prospective, blinded, randomized controlled clinical study where subjects act as their own control. The purpose of this study is to demonstrate that the ARTAS System is safe and effective for implanting follicular hair units. Patients will be followed for a nine months period of ...

Methods / trial design: Randomised, double-blind, vehicle-controlled multicentre trial in parallel groups. At screening (Visit 0), subjects will discontinue their previous treatment for alopecia areata, if any. Screening period will last up to 28 days. The 24-week treatment phase will include assessment Visits 1 to 3, which will take place ...

Hair loss is one of the most common complaints among all patients consulting a dermatologist and is usually associated with severe psychological disturbances, distress, and symptoms of depression. Most common forms of hair loss (alopecia) are caused by aberrant hair follicle cycling and changes in hair follicle morphology. Cells with ...